v3.26.1
Segment Reporting - Financial information for operating segments (Details) - EUR (€)
€ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting        
Net revenue € 7,524 € 7,212 € 6,592 [1]  
Material non-cash expenses (87) (12) 37  
Results of equity-accounted entities with activities similar to the Group (8) 37 64 [1]  
Other operating revenue and expenses (5,736) (5,609) (5,464)  
EBITDA 1,693 1,630 1,229  
Amortization (450) (438) (447)  
Operating Result 1,243 1,192 782 [1]  
Finance income 69 66 64  
Finance costs (697) (814) (639)  
Finance result (628) (748) (575) [1]  
Share of losses of equity accounted investees [1]     (1)  
Income tax expense (115) (231) (43) [1]  
Consolidated net profit 500 213 163 [1]  
Segment assets 18,241 19,227 19,170  
Equity-accounted investments 97 69 421 € 1,498
Unallocated assets 1,374 2,109 1,401  
Total assets 19,712 21,405 20,992  
Segment liabilities 3,544 3,443 3,105  
Unallocated liabilities 8,564 9,356 10,374  
Total liabilities 12,109 12,799 13,479  
Biopharma        
Segment Reporting        
Net revenue 6,487 6,143 5,558  
Diagnostic        
Segment Reporting        
Net revenue 640 645 670  
Bio Supplies        
Segment Reporting        
Net revenue 154 216 160  
Others        
Segment Reporting        
Net revenue 243 208 204  
Operating Segments | Biopharma        
Segment Reporting        
Net revenue 6,487 6,143 5,558  
Material non-cash expenses (99) (5) 30  
Results of equity-accounted entities with activities similar to the Group (8) (10) 2  
Other operating revenue and expenses (4,634) (4,529) (4,370)  
EBITDA 1,746 1,599 1,220  
Amortization (345) (328) (334)  
Operating Result 1,401 1,271 886  
Consolidated net profit 1,401 1,271 886  
Segment assets 13,411 14,233 13,420  
Equity-accounted investments 97 69 57  
Total assets 13,508 14,302 13,477  
Segment liabilities 2,175 2,324 2,460  
Total liabilities 2,175 2,324 2,460  
Operating Segments | Diagnostic        
Segment Reporting        
Net revenue 640 645 670  
Material non-cash expenses 3 5 7  
Other operating revenue and expenses (484) (476) (500)  
EBITDA 159 174 177  
Amortization (63) (65) (66)  
Operating Result 96 109 111  
Consolidated net profit 96 109 111  
Segment assets 3,389 3,755 3,529  
Total assets 3,389 3,755 3,529  
Segment liabilities 515 523 467  
Total liabilities 515 523 467  
Operating Segments | Bio Supplies        
Segment Reporting        
Net revenue 154 216 160  
Material non-cash expenses (1)      
Other operating revenue and expenses (104) (159) (107)  
EBITDA 49 57 53  
Amortization (9) (9) (9)  
Operating Result 40 48 44  
Consolidated net profit 40 48 44  
Segment assets 283 349 380  
Total assets 283 349 380  
Segment liabilities 43 82 80  
Total liabilities 43 82 80  
Operating Segments | Others        
Segment Reporting        
Net revenue 243 208 204  
Material non-cash expenses 2 (8) (1)  
Results of equity-accounted entities with activities similar to the Group   47 62  
Other operating revenue and expenses (271) (193) (241)  
EBITDA (26) 54 24  
Amortization (16) (16) (16)  
Operating Result (42) 38 8  
Consolidated net profit (42) 38 8  
Segment assets 855 890 1,841  
Equity-accounted investments     364  
Total assets 855 890 2,205  
Segment liabilities 576 514 98  
Total liabilities 576 514 98  
Intersegments        
Segment Reporting        
Other operating revenue and expenses     7  
EBITDA     7  
Operating Result     7  
Consolidated net profit     7  
Not Assignable        
Segment Reporting        
Material non-cash expenses 8 (4) 1  
Other operating revenue and expenses (243) (251) (253)  
EBITDA (235) (255) (252)  
Amortization (17) (19) (22)  
Operating Result (252) (274) (274)  
Finance income 69 66 64  
Finance costs (697) (814) (639)  
Finance result (628) (748) (575)  
Share of losses of equity accounted investees     (1)  
Income tax expense (115) (231) (43)  
Consolidated net profit (995) (1,253) (893)  
Segment assets 303      
Unallocated assets 1,374 2,109 1,401  
Total assets 1,677 2,109 1,401  
Segment liabilities 236      
Unallocated liabilities 8,564 9,356 10,374  
Total liabilities € 8,800 € 9,356 € 10,374  
[1] (See Note 2.d)